biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > JD's website

<< Previous

Bullboard Posts

Next >>

Comment by Sniper007on Feb 12, 2021 5:18pm

103 Views

Post# 32556273

RE:RE:RE:RE:JD's website

On the contrary, zwerp. I don't think you know what JD is capable of when he sets his mind to something; you haven't been around long enough.

I'm guessing that whatever JD writes on his website will likely capture the imagination of current shareholders, the board, and future/potential shareholders alike.

He's been quiet for far too long...

I agree. In the end, if the company doesn't execute, whatever JD writes will have little impact. Kinda makes sense though, doesn't it?!

<< Previous

Bullboard Posts

Next >>

NervGen Pharma: Proof that NVG-291 works?